Blood Products Market Size, Global Trends, Share And Growth Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Blood Products Market Size Analysis

Global Blood Products Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Whole Blood
  1. By Value
3. Red Blood Cells (RBCs)
  1. By Value
4. White Blood Cells
  1. By Value
5. Platelets
  1. By Value
6. Plasma
  1. By Value
  2. Fresh Frozen Plasma (FFP)
    1. Fresh Frozen Plasma (FFP) By Value
  3. Immunoglobulins
    1. Immunoglobulins By Value
  4. Albumin
    1. Albumin By Value
  5. Coagulation Factors
    1. Coagulation Factors By Value
7. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Anemia
  1. By Value
3. Hemophilia
  1. By Value
4. Surgical Procedures
  1. By Value
5. Trauma and Accident Care
  1. By Value
6. Cancer Treatment
  1. By Value
7. Immunodeficiency Diseases
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Blood Banks
  1. By Value
4. Diagnostic Laboratories
  1. By Value
5. Ambulatory Surgical Centers
  1. By Value
6. Others
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Whole Blood
  1. By Value
3. Red Blood Cells (RBCs)
  1. By Value
4. White Blood Cells
  1. By Value
5. Platelets
  1. By Value
6. Plasma
  1. By Value
  2. Fresh Frozen Plasma (FFP)
    1. Fresh Frozen Plasma (FFP) By Value
  3. Immunoglobulins
    1. Immunoglobulins By Value
  4. Albumin
    1. Albumin By Value
  5. Coagulation Factors
    1. Coagulation Factors By Value
7. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Anemia
  1. By Value
3. Hemophilia
  1. By Value
4. Surgical Procedures
  1. By Value
5. Trauma and Accident Care
  1. By Value
6. Cancer Treatment
  1. By Value
7. Immunodeficiency Diseases
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Blood Banks
  1. By Value
4. Diagnostic Laboratories
  1. By Value
5. Ambulatory Surgical Centers
  1. By Value
6. Others
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Whole Blood
    1. By Value
  3. Red Blood Cells (RBCs)
    1. By Value
  4. White Blood Cells
    1. By Value
  5. Platelets
    1. By Value
  6. Plasma
    1. By Value
    2. Fresh Frozen Plasma (FFP)
      1. Fresh Frozen Plasma (FFP) By Value
    3. Immunoglobulins
      1. Immunoglobulins By Value
    4. Albumin
      1. Albumin By Value
    5. Coagulation Factors
      1. Coagulation Factors By Value
  7. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Anemia
    1. By Value
  3. Hemophilia
    1. By Value
  4. Surgical Procedures
    1. By Value
  5. Trauma and Accident Care
    1. By Value
  6. Cancer Treatment
    1. By Value
  7. Immunodeficiency Diseases
    1. By Value
  8. Others
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals
    1. By Value
  3. Blood Banks
    1. By Value
  4. Diagnostic Laboratories
    1. By Value
  5. Ambulatory Surgical Centers
    1. By Value
  6. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Whole Blood
  1. By Value
3. Red Blood Cells (RBCs)
  1. By Value
4. White Blood Cells
  1. By Value
5. Platelets
  1. By Value
6. Plasma
  1. By Value
  2. Fresh Frozen Plasma (FFP)
    1. Fresh Frozen Plasma (FFP) By Value
  3. Immunoglobulins
    1. Immunoglobulins By Value
  4. Albumin
    1. Albumin By Value
  5. Coagulation Factors
    1. Coagulation Factors By Value
7. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Anemia
  1. By Value
3. Hemophilia
  1. By Value
4. Surgical Procedures
  1. By Value
5. Trauma and Accident Care
  1. By Value
6. Cancer Treatment
  1. By Value
7. Immunodeficiency Diseases
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Blood Banks
  1. By Value
4. Diagnostic Laboratories
  1. By Value
5. Ambulatory Surgical Centers
  1. By Value
6. Others
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Whole Blood
    1. By Value
  3. Red Blood Cells (RBCs)
    1. By Value
  4. White Blood Cells
    1. By Value
  5. Platelets
    1. By Value
  6. Plasma
    1. By Value
    2. Fresh Frozen Plasma (FFP)
      1. Fresh Frozen Plasma (FFP) By Value
    3. Immunoglobulins
      1. Immunoglobulins By Value
    4. Albumin
      1. Albumin By Value
    5. Coagulation Factors
      1. Coagulation Factors By Value
  7. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Anemia
    1. By Value
  3. Hemophilia
    1. By Value
  4. Surgical Procedures
    1. By Value
  5. Trauma and Accident Care
    1. By Value
  6. Cancer Treatment
    1. By Value
  7. Immunodeficiency Diseases
    1. By Value
  8. Others
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals
    1. By Value
  3. Blood Banks
    1. By Value
  4. Diagnostic Laboratories
    1. By Value
  5. Ambulatory Surgical Centers
    1. By Value
  6. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Whole Blood
  1. By Value
3. Red Blood Cells (RBCs)
  1. By Value
4. White Blood Cells
  1. By Value
5. Platelets
  1. By Value
6. Plasma
  1. By Value
  2. Fresh Frozen Plasma (FFP)
    1. Fresh Frozen Plasma (FFP) By Value
  3. Immunoglobulins
    1. Immunoglobulins By Value
  4. Albumin
    1. Albumin By Value
  5. Coagulation Factors
    1. Coagulation Factors By Value
7. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Anemia
  1. By Value
3. Hemophilia
  1. By Value
4. Surgical Procedures
  1. By Value
5. Trauma and Accident Care
  1. By Value
6. Cancer Treatment
  1. By Value
7. Immunodeficiency Diseases
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Blood Banks
  1. By Value
4. Diagnostic Laboratories
  1. By Value
5. Ambulatory Surgical Centers
  1. By Value
6. Others
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Whole Blood
    1. By Value
  3. Red Blood Cells (RBCs)
    1. By Value
  4. White Blood Cells
    1. By Value
  5. Platelets
    1. By Value
  6. Plasma
    1. By Value
    2. Fresh Frozen Plasma (FFP)
      1. Fresh Frozen Plasma (FFP) By Value
    3. Immunoglobulins
      1. Immunoglobulins By Value
    4. Albumin
      1. Albumin By Value
    5. Coagulation Factors
      1. Coagulation Factors By Value
  7. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Anemia
    1. By Value
  3. Hemophilia
    1. By Value
  4. Surgical Procedures
    1. By Value
  5. Trauma and Accident Care
    1. By Value
  6. Cancer Treatment
    1. By Value
  7. Immunodeficiency Diseases
    1. By Value
  8. Others
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals
    1. By Value
  3. Blood Banks
    1. By Value
  4. Diagnostic Laboratories
    1. By Value
  5. Ambulatory Surgical Centers
    1. By Value
  6. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Whole Blood
  1. By Value
3. Red Blood Cells (RBCs)
  1. By Value
4. White Blood Cells
  1. By Value
5. Platelets
  1. By Value
6. Plasma
  1. By Value
  2. Fresh Frozen Plasma (FFP)
    1. Fresh Frozen Plasma (FFP) By Value
  3. Immunoglobulins
    1. Immunoglobulins By Value
  4. Albumin
    1. Albumin By Value
  5. Coagulation Factors
    1. Coagulation Factors By Value
7. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Anemia
  1. By Value
3. Hemophilia
  1. By Value
4. Surgical Procedures
  1. By Value
5. Trauma and Accident Care
  1. By Value
6. Cancer Treatment
  1. By Value
7. Immunodeficiency Diseases
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Blood Banks
  1. By Value
4. Diagnostic Laboratories
  1. By Value
5. Ambulatory Surgical Centers
  1. By Value
6. Others
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Whole Blood
    1. By Value
  3. Red Blood Cells (RBCs)
    1. By Value
  4. White Blood Cells
    1. By Value
  5. Platelets
    1. By Value
  6. Plasma
    1. By Value
    2. Fresh Frozen Plasma (FFP)
      1. Fresh Frozen Plasma (FFP) By Value
    3. Immunoglobulins
      1. Immunoglobulins By Value
    4. Albumin
      1. Albumin By Value
    5. Coagulation Factors
      1. Coagulation Factors By Value
  7. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Anemia
    1. By Value
  3. Hemophilia
    1. By Value
  4. Surgical Procedures
    1. By Value
  5. Trauma and Accident Care
    1. By Value
  6. Cancer Treatment
    1. By Value
  7. Immunodeficiency Diseases
    1. By Value
  8. Others
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals
    1. By Value
  3. Blood Banks
    1. By Value
  4. Diagnostic Laboratories
    1. By Value
  5. Ambulatory Surgical Centers
    1. By Value
  6. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Whole Blood
  1. By Value
3. Red Blood Cells (RBCs)
  1. By Value
4. White Blood Cells
  1. By Value
5. Platelets
  1. By Value
6. Plasma
  1. By Value
  2. Fresh Frozen Plasma (FFP)
    1. Fresh Frozen Plasma (FFP) By Value
  3. Immunoglobulins
    1. Immunoglobulins By Value
  4. Albumin
    1. Albumin By Value
  5. Coagulation Factors
    1. Coagulation Factors By Value
7. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Anemia
  1. By Value
3. Hemophilia
  1. By Value
4. Surgical Procedures
  1. By Value
5. Trauma and Accident Care
  1. By Value
6. Cancer Treatment
  1. By Value
7. Immunodeficiency Diseases
  1. By Value
8. Others
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Blood Banks
  1. By Value
4. Diagnostic Laboratories
  1. By Value
5. Ambulatory Surgical Centers
  1. By Value
6. Others
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Whole Blood
    1. By Value
  3. Red Blood Cells (RBCs)
    1. By Value
  4. White Blood Cells
    1. By Value
  5. Platelets
    1. By Value
  6. Plasma
    1. By Value
    2. Fresh Frozen Plasma (FFP)
      1. Fresh Frozen Plasma (FFP) By Value
    3. Immunoglobulins
      1. Immunoglobulins By Value
    4. Albumin
      1. Albumin By Value
    5. Coagulation Factors
      1. Coagulation Factors By Value
  7. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Anemia
    1. By Value
  3. Hemophilia
    1. By Value
  4. Surgical Procedures
    1. By Value
  5. Trauma and Accident Care
    1. By Value
  6. Cancer Treatment
    1. By Value
  7. Immunodeficiency Diseases
    1. By Value
  8. Others
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals
    1. By Value
  3. Blood Banks
    1. By Value
  4. Diagnostic Laboratories
    1. By Value
  5. Ambulatory Surgical Centers
    1. By Value
  6. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Blood Products Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

CSL Limited
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Grifols S.A.
Baxter International Inc.
Takeda Pharmaceutical Company Limited
Octapharma AG
Bio-Rad Laboratories, Inc.
Haemonetics Corporation
LFB Group
Macopharma
Terumo Corporation

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment